Literature DB >> 18551321

The role of dexamethasone on decreasing urinary cytokines in children with acute pyelonephritis.

Mostafa Sharifian1, Navid Anvaripour, Abdollah Karimi, Alireza Fahimzad, Masoomeh Mohkam, Reza Dalirani, Fatemeh Gholikhani, Mohammad Ali Rafiee.   

Abstract

Cytokines play a major role in renal scar formation following febrile urinary tract infection (UTI). We investigated the role of dexamethasone combined with antibiotics in diminishing urinary interleukin-6 (UIL-6) and UIL-8 concentrations during the acute phase of pyelonephritis compared with standard antibiotic therapy. UIL-6 and UIL-8 concentrations were determined by enzyme immunoassay in 34 children with pyelonephritis who were treated with ceftriaxone plus dexamethasone (case group) and in 20 patients with the same diagnosis treated with ceftriaxone alone (control group). Urine samples were obtained at the time of presentation prior to drug administration and at follow-up 72 h after initiation of medication. Creatinine concentrations were also determined, and cytokine/creatinine ratios were calculated to standardize samples. Differences between cytokine/creatinine ratios in initial and follow-up urine samples were significant in the case group (P < 0.001) but not for controls. In addition, combined antibiotic and dexamethasone significantly decreased UIL-6 and UIL-8 concentrations compared with antibiotic alone (P < 0.05). We conclude that dexamethasone combined with antibiotics significantly decreases UIL-6 and UIL-8 levels in patients with acute pyelonephritis. This suggests that the clinical use of corticosteroids may prevent scar formation following febrile UTI.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18551321     DOI: 10.1007/s00467-008-0864-4

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  41 in total

1.  Adjunctive oral corticosteroids reduce renal scarring: the piglet model of reflux and acute experimental pyelonephritis.

Authors:  H G Pohl; H G Rushton; J S Park; R Chandra; M Majd
Journal:  J Urol       Date:  1999-09       Impact factor: 7.450

2.  Cytokine profiles of pediatric patients treated with antibiotics for pyelonephritis: potential therapeutic impact.

Authors:  K Kassir; O Vargas-Shiraishi; F Zaldivar; M Berman; J Singh; A Arrieta
Journal:  Clin Diagn Lab Immunol       Date:  2001-11

3.  Interleukin (IL)-6 and IL-8 in children with febrile urinary tract infection and asymptomatic bacteriuria.

Authors:  M Benson; U Jodal; W Agace; M Hellström; S Mårild; S Rosberg; M Sjöström; B Wettergren; S Jönsson; C Svanborg
Journal:  J Infect Dis       Date:  1996-11       Impact factor: 5.226

4.  Immunology of pyelonephritis in the primate model. VI. Effect of complement depletion.

Authors:  J A Roberts; J K Roth; G Domingue; R W Lewis; B Kaack; G Baskin
Journal:  J Urol       Date:  1983-01       Impact factor: 7.450

5.  Effects of melatonin on suppression of renal scarring in experimental model of pyelonephritis.

Authors:  Mustafa Imamoğlu; Ali Cay; Umit Cobanoglu; Elif Bahat; Caner Karahan; Ilknur Tosun; Haluk Sarihan
Journal:  Urology       Date:  2006-05-12       Impact factor: 2.649

6.  Effect of prednisolone on renal scarring in rats following infection with Serratia marcescens.

Authors:  M Haraoka; T Matsumoto; Y Mizunoe; N Ogata; K Takahashi; S Kubo; M Tanaka; J Kumazawa
Journal:  Ren Fail       Date:  1993       Impact factor: 2.606

7.  Renal scarring is enhanced by phorbol myristate acetate following infection with bacteria with mannose-sensitive pili.

Authors:  T Matsumoto; M Haraoka; Y Mizunoe; S Kubo; K Takahashi; M Tanaka; J Kumazawa
Journal:  Nephron       Date:  1993       Impact factor: 2.847

8.  Suppression of renal scarring by prednisolone combined with ciprofloxacin in ascending pyelonephritis in rats.

Authors:  M Haraoka; T Matsumoto; K Takahashi; S Kubo; M Tanaka; J Kumazawa
Journal:  J Urol       Date:  1994-04       Impact factor: 7.450

9.  Antioxidant effect on renal scarring following infection of mannose-sensitive-piliated bacteria.

Authors:  T Matsumoto; Y Mitzunoe; N Ogata; M Tanaka; K Takahashi; J Kumazawa
Journal:  Nephron       Date:  1992       Impact factor: 2.847

Review 10.  The inflammatory response and tissue damage. The example of renal scars following acute renal infection.

Authors:  M P Glauser; P Meylan; J Bille
Journal:  Pediatr Nephrol       Date:  1987-10       Impact factor: 3.714

View more
  8 in total

Review 1.  Corticosteroids for renal scar prevention in children with acute pyelonephritis.

Authors:  Teeranai Sakulchit; Ran D Goldman
Journal:  Can Fam Physician       Date:  2017-04       Impact factor: 3.275

2.  The effect of vitamin E or vitamin A on the prevention of renal scarring in children with acute pyelonephritis.

Authors:  Behnam Sobouti; Nakysa Hooman; Mansour Movahed
Journal:  Pediatr Nephrol       Date:  2012-10-07       Impact factor: 3.714

3.  Urine IL-8 concentrations in infectious and non-infectious urinary tract conditions.

Authors:  Maria Bitsori; Maria Karatzi; Helen Dimitriou; Eleni Christakou; Avrora Savvidou; Emmanouil Galanakis
Journal:  Pediatr Nephrol       Date:  2011-05-21       Impact factor: 3.714

4.  The effect of vitamin A on renal damage following acute pyelonephritis in children.

Authors:  Parviz Ayazi; Seyed Alireza Moshiri; Abolfazl Mahyar; Mona Moradi
Journal:  Eur J Pediatr       Date:  2010-09-18       Impact factor: 3.183

Review 5.  Use of antioxidants in urinary tract infection.

Authors:  Zahra Allameh; Jamshid Salamzadeh
Journal:  J Res Pharm Pract       Date:  2016 Apr-Jun

6.  Urinary Tract Infection in Children.

Authors:  Alexander K C Leung; Alex H C Wong; Amy A M Leung; Kam L Hon
Journal:  Recent Pat Inflamm Allergy Drug Discov       Date:  2019

7.  Could pyelonephritic scarring be prevented by anti-inflammatory treatment? An experimental model of acute pyelonephritis.

Authors:  Elif Bahat Özdoğan; Tuğba Özdemir; Seçil Arslansoyu Çamlar; Mustafa Imamoğlu; Ümit Cobanoğlu; Bircan Sönmez; İlknur Tosun; Ismail Doğan
Journal:  Biomed Res Int       Date:  2014-07-03       Impact factor: 3.411

8.  Oral steroids for reducing kidney scarring in young children with febrile urinary tract infections: the contribution of Bayesian analysis to a randomized trial not reaching its intended sample size.

Authors:  Liviana Da Dalt; Silvia Bressan; Floriana Scozzola; Enrico Vidal; Monia Gennari; Claudio La Scola; Mauro Anselmi; Elisabetta Miorin; Pietro Zucchetta; Danila Azzolina; Dario Gregori; Giovanni Montini
Journal:  Pediatr Nephrol       Date:  2021-05-25       Impact factor: 3.714

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.